CVS Health Corp
Held by 23 tracked managers as of Q2 2026 · CUSIP ⓘCUSIP: A 9-character ID for one specific security - one share class of one company, or one bond. Tickers can change and can mean different things in different countries; a CUSIP always identifies exactly the same security, which is why filings use it. Guide 126650100 · Sector ⓘGICS sectors: The 11-sector system most investors know (Global Industry Classification Standard): Technology, Health Care, Financials and so on. This site assigns each company a GICS-style sector from its SIC code, with a few hand corrections, so sector pages match the names investors expect. Guide
In plain English: 23 of the investors we track own this stock. In the latest quarter, 10 of them bought more of it and 13 sold some or all of theirs (3 bought it for the first time). That tells you what they did last quarter — not what the stock will do next.
Educational and informational only, not personalized investment advice. Based on public filings that may be delayed or contain errors; verify with the original filings. Disclaimer
Managers holding
23
+1 vs last quarter (like-for-like)
Total value held
$12.85B
Across tracked managers
Average weight ⓘOn average, how big this stock is in the portfolios that own it (its share of each manager's reported portfolio value).
1.6%
Of each manager's book
QoQ value ⓘLike-for-like: only managers that filed both quarters are compared, so a manager filing late (or confidentially) does not look like buying or selling. Includes price changes.
+$3.21B
+41.3% vs last quarter
Net shares bought
-2.0M
Est. net flow -$120.29M
Quarter activity
10 bought · 13 sold
3 new · 2 sold out
Tracked capital in this stock
Total value held (area) and number of managers (line). Dips can mean a large holder filed that quarter confidentially (e.g. Norges Bank in Q1/Q3).
Aggregate buying and selling
Net share change reported each quarter
Who owns CVS?
🔒 The 'who added and who trimmed' chart is a Plus feature
You're viewing the Free plan. Upgrade to unlock The 'who added and who trimmed' chart — every paid plan starts with a 7-day free trial, and you can cancel in two clicks.
Who owns CVS? — Q2 2026
Holders ranked by position size, with each one's quarter-over-quarter change.
Column filters
| # | Manager | Fund | Shares | Value ↓ | % of their portfolio | QoQ | Δ shares | Δ shares % | Est. Δ value ⓘChange in shares × this quarter's price |
|---|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox | Dodge & Cox | 50.01M | $5.17B | 2.7% | Reduced | -1.8M | -3.4% | -$182.83M |
| 2 | Norges Bank | Norges Bank Investment Management | 18.04M | $1.87B | 0.2% | — | — | — | — |
| 3 | Chris Davis | Davis Selected Advisers | 11.87M | $1.23B | 5.3% | Reduced | -373.8K | -3.1% | -$38.67M |
| 4 | Richard Pzena | Pzena Investment Management | 11.77M | $1.22B | 3.6% | Reduced | -2.0M | -14.5% | -$207.26M |
| 5 | Larry Robbins | Glenview Capital | 4.82M | $499.13M | 10.0% | Reduced | -3.4M | -41.1% | -$348.83M |
| 6 | Ken Griffin | Citadel Advisors | 4.81M | $497.86M | 0.3% | Reduced | -615.5K | -11.3% | -$63.67M |
| 7 | LSV Asset Management | LSV Asset Management | 4.64M | $479.52M | 0.9% | Added | +131.8K | +2.9% | +$13.63M |
| 8 | Andreas Halvorsen | Viking Global Investors | 3.66M | $378.97M | 1.1% | New | +3.7M | — | +$378.97M |
| 9 | Prem Watsa | Fairfax Financial Holdings | 2.71M | $280.50M | 10.6% | Held | 0 | 0.0% | $0 |
| 10 | Israel Englander | Millennium Management | 2.16M | $223.95M | 0.2% | Added | +2.0M | +1013.6% | +$203.84M |
| 11 | Boston Partners | Boston Partners Global Investors | 2.03M | $210.37M | 0.2% | Added | +1.9M | +1783.4% | +$199.20M |
| 12 | Steve Cohen | Point72 Asset Management | 1.96M | $202.87M | 0.3% | New | +2.0M | — | +$202.87M |
| 13 | Charles Brandes | Brandes Investment Partners | 1.67M | $173.21M | 1.2% | Reduced | -295.5K | -15.0% | -$30.57M |
| 14 | David Shaw | D.E. Shaw & Co. | 1.38M | $142.97M | 0.1% | Reduced | -235.5K | -14.6% | -$24.36M |
| 15 | John Rogers | Ariel Investments | 730.11K | $75.53M | 0.8% | Added | +28.0K | +4.0% | +$2.89M |
| 16 | Jeremy Grantham | GMO | 541.12K | $55.98M | 0.1% | Reduced | -93.7K | -14.8% | -$9.70M |
| 17 | Jim Simons | Renaissance Technologies | 441.02K | $45.62M | 0.1% | Added | +177.9K | +67.6% | +$18.40M |
| 18 | Ray Dalio | Bridgewater Associates | 440.97K | $45.62M | 0.2% | Reduced | -177.5K | -28.7% | -$18.36M |
| 19 | Bill Nygren | Harris Associates (Oakmark Funds) | 335.82K | $34.74M | 0.0% | Reduced | -158.3K | -32.0% | -$16.38M |
| 20 | Mario Gabelli | GAMCO Investors | 93.72K | $9.70M | 0.1% | Added | +498 | +0.5% | +$51.52K |
| 21 | Ken Fisher | Fisher Asset Management | 92.01K | $9.52M | 0.0% | Added | +3.6K | +4.1% | +$374.28K |
| 22 | Fred Alger | Fred Alger Management | 26.48K | $2.74M | 0.0% | New | +26.5K | — | +$2.74M |
| 23 | Beutel Goodman | Beutel, Goodman & Co | 600 | $62.00K | 0.0% | Reduced | -5.3K | -89.8% | -$544.05K |
Column filters
| Manager | Fund | Shares sold | Value last quarter ↓ |
|---|---|---|---|
| Hotchkis & Wiley | Hotchkis & Wiley Capital Management | -2.8M | $200.72M |
| Tweedy, Browne & Co | Tweedy, Browne Company LLC | -19.1K | $1.37M |
Politician trades
Column filters
| Politician | Date | Ticker | Asset | Type | Reported range ⓘThe dollar range the politician reported. Exact amounts are not disclosed. | Est. size ⓘOur estimate only: the midpoint of the reported range. | Owner | Account ⓘSubholding Of: the account the trade was in, as named on the report (e.g. an IRA or a brokerage account). The same stock bought on the same day in different accounts is a separate trade in each account. | Filed ↓ | Filing delay ⓘDays between the trade and the report. Over 45 days is late under the STOCK Act. | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ro Khanna Politician | Sep 4, 2026 | CVS | CVS HEALTH CORP CMN scanned | Sale (partial) | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Spouse | — | Oct 7, 2026 | 33 days | PTR ↗ |
| Dwight Evans Politician | Nov 21, 2025 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | PERSHING LLC | May 15, 2026 | 175 days Late | PTR ↗ |
| Ro Khanna Politician | Apr 13, 2026 | CVS | CVS HEALTH CORP CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | May 11, 2026 | 28 days | PTR ↗ |
| Ro Khanna Politician | Jan 29, 2026 | CVS | CVS HEALTH CORP CMN scanned | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Feb 6, 2026 | 8 days | PTR ↗ |
| Dwight Evans Politician | Nov 21, 2025 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | PERSHING LLC | Dec 19, 2025 | 28 days | PTR ↗ |
| Val T. Hoyle Politician | Sep 23, 2025 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Oct 10, 2025 | 17 days | PTR ↗ |
| Val T. Hoyle Politician | Oct 29, 2024 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Sep 12, 2025 | 318 days Late | PTR ↗ |
| Ro Khanna Politician | Aug 4, 2025 | CVS | CVS HEALTH CORP CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Sep 9, 2025 | 36 days | PTR ↗ |
| Adam Smith Politician | Aug 8, 2025 | CVS | CVS Health Corporation Common Stock (CVS) [ST] Beneficiary | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | Baird Trust Company TTEE FBO/Inherited Beneficiary IRA/John Eldridge Deceased IRA/Sara Smith | Aug 8, 2025 | 0 days | PTR ↗ |
| Ro Khanna Politician | May 28, 2025 | CVS | CVS HEALTH CORP CMN scanned | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Jun 10, 2025 | 13 days | PTR ↗ |
| Julie Johnson Politician | Apr 1, 2025 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Merrill Lynch Tax Efficient Core | May 14, 2025 | 43 days | PTR ↗ |
| Ro Khanna Politician | Mar 6, 2025 | CVS | CVS HEALTH CORP CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Apr 10, 2025 | 35 days | PTR ↗ |
| Ro Khanna Politician | Mar 12, 2025 | CVS | CVS HEALTH CORP CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Apr 10, 2025 | 29 days | PTR ↗ |
| Julie Johnson Politician | Jan 15, 2025 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Joint | Merrill Lynch Tax Efficient Core | Feb 12, 2025 | 28 days | PTR ↗ |
| Gil Cisneros Politician | Jan 24, 2025 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | 150 Main Street Trust > Bank of America | Feb 11, 2025 | 18 days | PTR ↗ |
| Ro Khanna Politician | Jan 17, 2025 | CVS | CVS HEALTH CORP CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Feb 6, 2025 | 20 days | PTR ↗ |
| Ro Khanna Politician | Jan 22, 2025 | CVS | CVS HEALTH CORP CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Feb 6, 2025 | 15 days | PTR ↗ |
| Ro Khanna Politician | Dec 16, 2024 | CVS | CVS HEALTH CORP CMN scanned | Sale (partial) | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Jan 8, 2025 | 23 days | PTR ↗ |
| Ro Khanna Politician | Dec 18, 2024 | CVS | CVS HEALTH CORP CMN scanned | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Jan 8, 2025 | 21 days | PTR ↗ |
| Thomas R. Suozzi Politician | Oct 24, 2024 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Merrill Lynch- Advisor Discretion Account- IRA | Nov 12, 2024 | 19 days | PTR ↗ |
| Ro Khanna Politician | Aug 2, 2024 | CVS | CVS HEALTH CORP CMN scanned | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Spouse | — | Sep 6, 2024 | 35 days | PTR ↗ |
| Ro Khanna Politician | Jul 1, 2024 | CVS | CVS HEALTH CORP CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Spouse | — | Aug 7, 2024 | 37 days | PTR ↗ |
| Ro Khanna Politician | Jul 2, 2024 | CVS | CVS HEALTH CORP CMN scanned | Purchase | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | — | — | Aug 7, 2024 | 36 days | PTR ↗ |
| Ro Khanna Politician | May 28, 2024 | CVS | CVS HEALTH CORP CMN scanned | Sale | $15,001 - $50,000 | Est. $32,500 (midpoint of reported range $15,001–$50,000) | Spouse | — | Jun 5, 2024 | 8 days | PTR ↗ |
| William R. Keating Politician | May 17, 2024 | CVS | CVS Health Corporation Common Stock (CVS) [ST] | Sale | $1,001 - $15,000 | Est. $8,000 (midpoint of reported range $1,001–$15,000) | Self | Bill's IRA | May 22, 2024 | 5 days | PTR ↗ |